Church & Dwight (NYSE:CHD) Price Target Raised to $104.00

Church & Dwight (NYSE:CHD) had its target price hoisted by Bank of America from $100.00 to $104.00 in a research note issued to investors on Monday morning, Benzinga reports. They currently have a neutral rating on the stock.

A number of other brokerages have also commented on CHD. The Goldman Sachs Group began coverage on Church & Dwight in a report on Friday, March 1st. They issued a buy rating and a $110.00 price target on the stock. Barclays boosted their price target on Church & Dwight from $80.00 to $83.00 and gave the company an underweight rating in a report on Friday. TheStreet upgraded Church & Dwight from a c+ rating to a b rating in a report on Friday, February 2nd. Stifel Nicolaus upped their target price on Church & Dwight from $91.00 to $99.00 and gave the stock a hold rating in a report on Monday, February 5th. Finally, Argus upgraded Church & Dwight from a hold rating to a buy rating and set a $115.00 target price on the stock in a report on Friday, February 23rd. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of Hold and an average price target of $103.27.

Church & Dwight Stock Performance

CHD stock opened at $101.63 on Monday. The business’s 50-day moving average price is $101.72 and its two-hundred day moving average price is $96.23. The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of 0.57. The firm has a market cap of $24.79 billion, a PE ratio of 33.43, a P/E/G ratio of 3.48 and a beta of 0.53. Church & Dwight has a 1-year low of $82.25 and a 1-year high of $105.67.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Friday, February 2nd. The company reported $0.65 EPS for the quarter, meeting analysts’ consensus estimates of $0.65. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.51 billion. Church & Dwight had a return on equity of 20.28% and a net margin of 12.88%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.62 earnings per share. As a group, research analysts forecast that Church & Dwight will post 3.44 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 1st. Stockholders of record on Thursday, February 15th were given a $0.2838 dividend. This is an increase from Church & Dwight’s previous quarterly dividend of $0.27. The ex-dividend date was Wednesday, February 14th. This represents a $1.14 annualized dividend and a dividend yield of 1.12%. Church & Dwight’s dividend payout ratio is presently 37.17%.

Insider Activity

In other news, EVP Michael Read sold 4,500 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $105.00, for a total value of $472,500.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, EVP Michael Read sold 4,500 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The stock was sold at an average price of $105.00, for a total value of $472,500.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Rene Hemsey sold 9,280 shares of the firm’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $100.22, for a total value of $930,041.60. Following the transaction, the executive vice president now owns 6,373 shares in the company, valued at approximately $638,702.06. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 373,052 shares of company stock valued at $38,603,796. 1.40% of the stock is owned by insiders.

Hedge Funds Weigh In On Church & Dwight

Hedge funds have recently added to or reduced their stakes in the stock. Game Plan Financial Advisors LLC bought a new position in Church & Dwight during the 1st quarter worth $26,000. Roble Belko & Company Inc bought a new position in Church & Dwight during the 1st quarter worth $31,000. Chilton Capital Management LLC boosted its holdings in shares of Church & Dwight by 50.0% in the 4th quarter. Chilton Capital Management LLC now owns 330 shares of the company’s stock valued at $31,000 after purchasing an additional 110 shares in the last quarter. Harbour Investments Inc. boosted its holdings in shares of Church & Dwight by 1,033.3% in the 4th quarter. Harbour Investments Inc. now owns 340 shares of the company’s stock valued at $32,000 after purchasing an additional 310 shares in the last quarter. Finally, Creekmur Asset Management LLC acquired a new stake in shares of Church & Dwight in the 4th quarter valued at $32,000. Institutional investors own 86.60% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.